Xue-Feng Bai, MD, PhD
Xue-Feng Bai, MD, PhD is an Associate Professor in the Experimental Pathology Branch. He earned his MD from the Third Medical University of PLA, Chongqqing China and his PhD at the Karolinska Institute in Stockholm, Sweden. He completed one year of postdoctoral training in the Division of Immunology, Department of Pathology at New York University Medical Center in New York City and two years of postdoctoral training in the Department of Pathology at The Ohio State University Medical Center. Dr. Bai’s research focuses on T cell responses in autoimmune diseases and cancer immunotherapy.
Title: IL-27 and cancer susceptibility to anti-PD1 therapy
Sponsor: National Cancer Institute
Dates: 04/01/2016 - 03/30/2018
Academic and Medical Appointments
2010-present Associate Professor, Department of Pathology, The Ohio State University
2005-present Graduate Faculty (PhD Adviser), The Ohio State University College of Medicine, Integrated Biomedical Science Graduate Program (IBGP)
2003-present Member, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital & Solove Research Institute. Columbus, OH
Education and Training
1998-2000 Postdoctoral Associate, Immunology, The Ohio State University Department of Pathology, Columbus, OH
1998 Ph.D., Karolinska Institute, Stockholm, Sweden
1988-1990 Resident, Internal medicine, Third Military Medical University, Chongqing, China.
1988 M.D., Third Military Medical University, Chongqing, China